Kim Bo-Yeon, Kang Seon Mee, Kang Jee-Hyun, Kang Seo Young, Kim Kyoung Kon, Kim Kyoung-Bae, Kim Bomtaeck, Kim Seung Jun, Kim Yang-Hyun, Kim Jung-Hwan, Kim Jae Hyun, Kim Eun Mi, Nam Ga Eun, Park Ji Yeon, Son Jang Won, Shin Yun-A, Shin Hye-Jung, Oh Tae Jung, Lee Hyug, Jeon Eon-Ju, Chung Sochung, Hong Yong Hee, Kim Chong Hwa
Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
J Obes Metab Syndr. 2021 Jun 30;30(2):81-92. doi: 10.7570/jomes21022.
Obesity is a prevalent and complex disease. The prevalence of obesity in Korea increased from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being 23.8% in 2018. Obesity contributes to medical costs and socioeconomic burden due to associated comorbidities. The treatment and management of obesity is changing based on new clinical evidence. The 2020 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea summarizes evidence-based recommendations and treatment guidelines.
肥胖是一种普遍且复杂的疾病。韩国肥胖症的患病率从2010年的29.7%上升至2018年的35.7%,2018年腹型肥胖的患病率为23.8%。由于相关合并症,肥胖会增加医疗成本和社会经济负担。基于新的临床证据,肥胖的治疗和管理正在发生变化。《2020年韩国肥胖研究学会韩国肥胖管理指南》总结了循证建议和治疗指南。